My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 272

    1.

    Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes.

    Martina V, Masha A, Gigliardi VR, Brocato L, Manzato E, Berchio A, Massarenti P, Settanni F, Della Casa L, Bergamini S, Iannone A.

    Diabetes Care. 2008 May;31(5):940-4. Epub 2008 Feb 11.PMID: 18268065 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Oral L-arginine improves endothelial dysfunction in patients with essential hypertension.

    Lekakis JP, Papathanassiou S, Papaioannou TG, Papamichael CM, Zakopoulos N, Kotsis V, Dagre AG, Stamatelopoulos K, Protogerou A, Stamatelopoulos SF.

    Int J Cardiol. 2002 Dec;86(2-3):317-23.PMID: 12419572 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.

    Giugliano D, Marfella R, Acampora R, Giunta R, Coppola L, D'Onofrio F.

    Diabetes Care. 1998 Apr;21(4):631-6.PMID: 9571355 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.

    Miller AL.

    Altern Med Rev. 2006 Mar;11(1):23-9.PMID: 16597191 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles.

    Swaminathan K, Davies J, George J, Rajendra NS, Morris AD, Struthers AD.

    Diabetologia. 2008 May;51(5):762-8. Epub 2008 Mar 18.PMID: 18347776 [PubMed - indexed for MEDLINE]Related articles

    6.

    Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes.

    De Mattia G, Bravi MC, Laurenti O, Cassone-Faldetta M, Proietti A, De Luca O, Armiento A, Ferri C.

    Diabetologia. 1998 Nov;41(11):1392-6.PMID: 9833950 [PubMed - indexed for MEDLINE]Related articles

    7.

    Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes.

    Schmieder RE, Delles C, Mimran A, Fauvel JP, Ruilope LM.

    Diabetes Care. 2007 Jun;30(6):1351-6. Epub 2007 Mar 2. Erratum in: Diabetes Care. 2007 Sep;30(9):2421. PMID: 17337492 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus.

    Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM, Bank AJ.

    Vasc Med. 2007 Nov;12(4):311-8.PMID: 18048467 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.

    Flammer AJ, Hermann F, Wiesli P, Schwegler B, Chenevard R, Hürlimann D, Sudano I, Gay S, Neidhart M, Riesen W, Ruschitzka F, Lüscher TF, Noll G, Lehmann R.

    J Hypertens. 2007 Apr;25(4):785-91.PMID: 17351370 [PubMed - indexed for MEDLINE]Related articles

    10.

    Repaglinide administration improves brachial reactivity in type 2 diabetic patients.

    Manzella D, Grella R, Abbatecola AM, Paolisso G.

    Diabetes Care. 2005 Feb;28(2):366-71.PMID: 15677794 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

    Sorrentino SA, Bahlmann FH, Besler C, Müller M, Schulz S, Kirchhoff N, Doerries C, Horváth T, Limbourg A, Limbourg F, Fliser D, Haller H, Drexler H, Landmesser U.

    Circulation. 2007 Jul 10;116(2):163-73. Epub 2007 Jun 25.PMID: 17592079 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes.

    Aversa A, Vitale C, Volterrani M, Fabbri A, Spera G, Fini M, Rosano GM.

    Diabet Med. 2008 Jan;25(1):37-44.PMID: 18199130 [PubMed - indexed for MEDLINE]Related articles

    13.

    Diabetic endothelial dysfunction: effect of free radical scavenging in Type 2 diabetic patients.

    De Mattia G, Laurenti O, Fava D.

    J Diabetes Complications. 2003 Mar-Apr;17(2 Suppl):30-5.PMID: 12623166 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.

    Bank AJ, Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM.

    Am J Hypertens. 2007 Jul;20(7):777-83.PMID: 17586413 [PubMed - indexed for MEDLINE]Related articles

    15.

    N-acetylcysteine is able to reduce the oxidation status and the endothelial activation after a high-glucose content meal in patients with Type 2 diabetes mellitus.

    Masha A, Brocato L, Dinatale S, Mascia C, Biasi F, Martina V.

    J Endocrinol Invest. 2009 Apr;32(4):352-6.PMID: 19636205 [PubMed - indexed for MEDLINE]Related articles

    16.

    Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilation in Type 2 diabetes.

    Fava D, Cassone-Faldetta M, Laurenti O, De Luca O, Ghiselli A, De Mattia G.

    Diabet Med. 2002 Sep;19(9):752-7.PMID: 12207812 [PubMed - indexed for MEDLINE]Related articles

    17.

    Oral arginine reduces systemic blood pressure in type 2 diabetes: its potential role in nitric oxide generation.

    Huynh NT, Tayek JA.

    J Am Coll Nutr. 2002 Oct;21(5):422-7.PMID: 12356784 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.

    Lucotti P, Monti L, Setola E, La Canna G, Castiglioni A, Rossodivita A, Pala MG, Formica F, Paolini G, Catapano AL, Bosi E, Alfieri O, Piatti P.

    Metabolism. 2009 Sep;58(9):1270-6. Epub 2009 Jul 9.PMID: 19592054 [PubMed - indexed for MEDLINE]Related articles

    19.

    High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance.

    Chen H, Karne RJ, Hall G, Campia U, Panza JA, Cannon RO 3rd, Wang Y, Katz A, Levine M, Quon MJ.

    Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H137-45. Epub 2005 Aug 26.PMID: 16126809 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes.

    Davies JI, Band M, Morris A, Struthers AD.

    Diabetologia. 2004 Oct;47(10):1687-94. Epub 2004 Sep 9.PMID: 15365622 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity